argenx SE reported 38.4M in Interest Income for its fiscal quarter ending in June of 2025.


Interest Income Change Date
AstraZeneca 68M 16M Jun/2025
Galapagos EUR 12.56M 4.66M Mar/2025
Genmab DKK 25M 8M Jun/2025
GlaxoSmithKline 50M 4M Jun/2025
GRIFOLS 9.56M 4.5M Jun/2025
Hikma Pharmaceutical 4M 0 Dec/2024
Qiagen NV USD 13.86M 1.53M Jun/2025